AU:IVX Stock Latest News
Company AnnouncementsInvion Announces Philip Wood Board Appointment and Company Secretary Change4d ago
Company AnnouncementsInvion secures major funding as Photosoft cancer trial advances to Phase II2w ago
Company AnnouncementsInvion Moves to Fully Virtual AGM and Paperless Meeting Materials3w ago
Company AnnouncementsInvion Plans New Share and Option Issue in ASX Placement3w ago
Company AnnouncementsInvion secures financing to cover up to 85% of clinical trial costs3w ago
Company AnnouncementsInvion and Percheron Align on Novel Cancer Combination Using Photosoft and VISTA Immunotherapy3w agoCompany AnnouncementsInvion Advances Photosoft-Based Skin Cancer Therapy After Strong Phase I Safety Readouts3w ago
Company AnnouncementsInvion Plans ASX Share Placement to Boost Capital1M ago
Company AnnouncementsInvion Secures $400,000 in Director Loans to Support Working Capital1M ago
Company AnnouncementsInvion Sets Out 2026 Governance Framework and Board Changes2M ago
Company AnnouncementsInvion Narrows Annual Loss but Net Tangible Assets Slide Deeper Into Negative Territory2M ago
Company AnnouncementsInvion Appoints New Director With No Current Securities Interests2M agoCompany AnnouncementsInvion strengthens clinical leadership and expands Photosoft into new cancer and eye indications3M ago
Company AnnouncementsInvion Issues New Tranches of Unquoted Options to Strengthen Capital Structure4M ago
Company AnnouncementsInvion Seeks ASX Quotation for New Series of Options4M ago
Company AnnouncementsInvion boosts PDT push with appointment of global clinical leader Colin Hopper4M ago
Company AnnouncementsInvion boosts director equity stake with new incentive options4M ago
Company AnnouncementsInvion Issues 671,882 Unquoted Convertible Notes as Part of Funding Strategy5M ago
Company AnnouncementsInvion secures strong shareholder backing for capital measures at EGM5M ago


